GSK receives European and CHMP approval for stem cell gene therapy – DIGITALLOOK
DIGITALLOOK |
GSK receives European and CHMP approval for stem cell gene therapy
DIGITALLOOK GlaxoSmithKline has been given encouraging support for a stem cell gene therapy that uses an individual patient's own cells to treat a very rare immunodeficiency disorder in children. The Committee for Medicinal Products for Human Use (CHMP) of the … |
